Clinical Overview

“ST Tilt Up” (STTU) is a descriptive label from the dataset behind this simulator’s real-record library (Zheng et al., “A 12-lead electrocardiogram database for arrhythmia research covering more than 10,000 patients,” Chapman-Shaoxing/Ningbo cohort, PhysioNet/Scientific Data 2020), not itself a diagnosis with its own textbook chapter. Unlike several of its own dataset near-neighbors, STTU’s underlying SNOMED CT code resolves cleanly and specifically to one concept: independent lookups against two separately hosted HL7 FHIR terminology servers (SNOMED CT International edition, release 20250201) both return the identical result for STTU’s code — “ST elevation (observable entity)” — and that agrees with a prior cross-dataset check against the PhysioNet/Computing in Cardiology Challenge’s own SNOMED mapping, built from an entirely different set of source ECG databases. Despite its nonstandard “Tilt Up” phrasing, STTU is this dataset’s label for genuine ST-segment elevation: the J point (the junction between the QRS complex and the ST segment) displaced above the isoelectric baseline. This page uses the standard clinical term “ST Elevation” as its title for that reason, keeping the dataset’s own “ST Tilt Up” wording available as a search alias.

This confirmed direction is what sets STTU apart from its closest-sounding dataset neighbor, “ST Extension” (STE): despite how similar the two names read at a glance, STE’s own SNOMED code resolves only to the generic “ST interval abnormal” concept and does not confirm any direction, so STE and STTU are not interchangeable (see Differential Diagnosis). This project’s own review of how the labels are actually applied in the dataset’s records found that pattern reflected in practice: STTU-tagged records do not co-occur with an STE tag or with the other direction-unspecified umbrella tag, “ST Changes” (STC) — consistent with annotators treating STTU as a specific, confirmed-direction category rather than a variant of the generic tags. What that confirmed direction does not settle is the underlying cause. STTU marks that the ST segment is elevated, not why: the same surface appearance is produced by several distinct processes, and this dataset’s own source publication does not document the amplitude, lead-count, or morphology threshold its original annotators required before applying the tag.

Mechanistically, ST elevation is a shared final appearance rather than a single process. In acute coronary occlusion (ST-elevation myocardial infarction, or STEMI), transmural ischemia from plaque rupture and thrombus formation creates an “injury current” — an abnormal voltage gradient between ischemic and healthy myocardium during the plateau phase of the action potential — that displaces the J point and ST segment above baseline in the leads overlying the affected territory, typically with reciprocal depression in electrically opposite leads. Benign early repolarization produces a similar-looking but mechanistically distinct elevation, driven by an accentuated transient outward potassium current during phase 1 of the action potential in a subset of otherwise healthy hearts. A third category — left ventricular hypertrophy with a strain pattern, and left bundle branch block — produces “appropriately discordant” ST elevation in leads with deep S waves (classically V1-V3) as a secondary consequence of an abnormal depolarization sequence, not from ischemia or a channel effect at all. Acute pericarditis produces diffuse, inflammation-driven elevation across most of the 12-lead tracing rather than a single vascular territory.

Because the label does not confirm which of these processes is present, ST elevation is treated as one of the higher-acuity findings a monitoring technician can encounter, precisely because it cannot be assumed benign from the tag alone. The 2023 ESC guideline for acute coronary syndromes frames ST-elevation ACS as generally reflecting an acute total or subtotal coronary occlusion, with primary percutaneous coronary intervention as the default treatment; current STEMI ECG criteria require new ST elevation at the J point in at least two contiguous leads, at a threshold of at least 0.1 mV (1 mm) in most leads and a sex- and age-adjusted threshold in V2-V3 (greater than 0.2 mV in men 40 or older, greater than 0.25 mV in men under 40, and greater than 0.15 mV in women). Time to reperfusion is itself a driver of outcome: prompt primary PCI within 120 minutes of presentation is associated with meaningfully lower mortality than a delayed intervention. Set against that, a stable, unchanged, concave elevation in a young, asymptomatic patient is far more often a benign early repolarization variant than an emergency — the same appearance, read in the wrong context, can go either way.

Because STTU is a label for an ECG appearance rather than a disease, it has no symptom profile of its own; any symptoms present come from whichever underlying process is producing the elevation. The classic ischemic presentation is chest discomfort described as pain, pressure, tightness, heaviness, or a burning sensation, often accompanied by dyspnea, diaphoresis, or radiation to the arm, jaw, or back, while a benign early-repolarization pattern is typically an incidental finding in an asymptomatic, otherwise healthy person and pericarditis classically produces pleuritic chest pain that improves with sitting forward.

The categories of underlying process most often producing ST elevation, per standard ECG teaching, include: acute myocardial infarction from coronary plaque rupture and thrombosis, coronary vasospasm, acute pericarditis, benign early repolarization (most common in young, male, and athletic individuals), a discordant secondary pattern from left ventricular hypertrophy or left bundle branch block, and, less commonly, Takotsubo (stress) cardiomyopathy or hyperkalemia. Underlying coronary artery disease, uncontrolled hypertension, diabetes, hyperlipidemia, smoking, and older age raise the likelihood that a new elevation reflects an acute ischemic process rather than a benign or structural variant. STTU tags in this dataset fairly often co-occur with the dataset’s abnormal-Q-wave tag and, less often, with its side-wall myocardial-infarction tag — evidence that a genuine infarction explains some, but clearly not all, STTU-tagged tracings, which is itself a reminder that the tag spans the full range of elevation causes above rather than confirming any single one.

Interpretation Guide

Key Features:

• Rate: not defining for this label — depends entirely on the accompanying rhythm
• Rhythm: not defining — STTU is superimposed on an underlying rhythm rather than describing the rhythm itself
• P waves: within normal limits for the underlying rhythm; not part of this finding
• PR interval: within normal limits for the underlying rhythm; not part of this finding
• QRS complex: normal (<0.12 s) unless a coexisting bundle branch block or voltage criteria for left ventricular hypertrophy are present, in which case the resulting ST elevation should be attributed to that secondary, “appropriately discordant” pattern rather than treated as an independent, unexplained finding
• ST segment: the defining feature, and — unlike some of this label’s own dataset neighbors — the direction is confirmed: the J point is displaced above the isoelectric baseline. What the label does not confirm is magnitude, lead count, or morphology; standard STEMI criteria require at least 0.1 mV of elevation in most leads (sex- and age-adjusted in V2-V3) across at least two contiguous leads, but this dataset’s own documentation does not state whether STTU was applied at that threshold, at any visible elevation, or somewhere in between, so evaluate the actual tracing rather than assuming a magnitude from the tag alone
• T waves: often altered alongside the ST segment as ischemia evolves (hyperacute, peaked T waves can precede visible elevation by minutes to hours; T-wave inversion typically follows over the ensuing days as pathologic Q waves develop), and T Wave Change (TWC) tags frequently accompany STTU tags in this dataset — but T-wave change is still its own separate dataset label, so do not assume T-wave involvement from an STTU tag alone
• QT interval: not defining on its own, though acute ischemia and some of STTU’s other underlying causes can prolong it
• Other findings: reciprocal ST depression in electrically opposite leads supports an acute ischemic process over a benign or structural cause; always compare against a prior ECG when one is available, since a new or dynamic change carries materially more weight than a stable, longstanding one; correlate with symptoms, vital signs, and cardiac biomarkers when the change is new

Key Leads

• All 12 leads — not lead-agnostic: which leads show the elevation determines both the likely coronary territory (if ischemic) and how urgently it should be treated, so a full 12-lead assessment is required rather than reading a single lead in isolation
• II, III, aVF — the inferior distribution, classically associated with right coronary or left circumflex artery occlusion when the cause is ischemic; check for reciprocal ST depression in I and aVL
• V1-V4 — the anteroseptal/anterior distribution, classically associated with left anterior descending artery occlusion when the cause is ischemic; this is also the distribution where a discordant elevation from left bundle branch block or left ventricular hypertrophy strain is expected, so voltage criteria and QRS morphology should be checked before assuming an ischemic cause here specifically
• I, aVL, V5, V6 — the lateral distribution, classically associated with left circumflex artery occlusion when the cause is ischemic; check for reciprocal ST depression in III and aVF
• Leads showing reciprocal depression — a lead pair with elevation in one and depression in the electrically opposite lead is itself supportive of an acute, localized ischemic process rather than a diffuse (pericarditis) or generalized (early repolarization) benign pattern

Differential Diagnosis

• ST Depression (STDD, this app’s dataset label “ST Drop Down”) — the opposite direction of ST-segment displacement. The two are not mutually exclusive on the same tracing: STDD tags fairly commonly co-occur with STTU tags in this dataset, consistent with a genuine reciprocal pattern (elevation in one territory paired with depression in an electrically opposite lead) rather than a labeling error.
• ST Changes (STC) — this dataset’s other, more generic “the ST segment looks altered” tag, which does not itself specify a direction. STC and STTU do not co-occur on the same record in this dataset, consistent with STTU functioning as the more specific, confirmed-direction label rather than a subtype of STC.
• Early Repolarization Pattern (ERV) — the most important benign mimic: a concave, “fish-hook” elevation, most often in the precordial and/or inferolateral leads, typically stable across serial tracings, most common in young, male, and athletic patients, and defined by a specific terminal-QRS notch or slur that STTU’s own dataset criteria do not require. STTU and ERV do not co-occur on the same record in this dataset either, even though the two ECG appearances can look similar at the bedside — a reminder that the dataset’s own labeling boundary and the clinical differential are not the same question.
• Myocardial Infarction In The Side Wall (MISW) — this dataset’s own label for a diagnosed lateral-wall infarction. Only a minority of STTU-tagged records also carry an MISW tag, meaning a genuine infarction diagnosis explains just some of this dataset’s elevation-tagged tracings; most reflect one of this section’s other, non-infarction causes, which is exactly why an STTU tag should prompt evaluation rather than an assumption of infarction.
• Left Ventricle Hypertrophy (LVH) — a structural cause of discordant ST elevation, typically confined to the right precordial leads (V1-V3) with deep S waves, accompanied by ST depression and asymmetric T-wave inversion in the lateral leads and by voltage criteria for hypertrophy elsewhere on the same tracing. This pattern reflects an abnormal depolarization sequence rather than ischemia.

Treatment Brief

An ST elevation finding is one of the highest-acuity ECG appearances a monitoring technician can encounter, precisely because the label itself does not distinguish an emergency from a benign variant.

• Read the actual ST segment, its morphology (concave versus convex or “tombstone”), and its lead distribution before assuming a cause; the STTU label confirms elevation but not etiology.
• Notify the provider promptly for any new or symptomatic ST elevation and treat it with the same urgency as a possible acute coronary occlusion until excluded — confirm accurate lead placement, obtain or repeat a 12-lead ECG, and ensure IV access and continuous cardiac monitoring are in place.
• Compare against a prior ECG whenever one is available; a stable, unchanged appearance over time favors a benign variant, while a new or dynamic change favors an acute process.
• Look for reciprocal ST depression in electrically opposite leads and for evolving T-wave or Q-wave changes on serial tracings, both of which favor an ischemic process over a benign or structural one.
• Obtain cardiac biomarkers (troponin) and correlate with the patient’s symptoms and vital signs before assigning any significance to an isolated finding.
• Check voltage criteria for left ventricular hypertrophy and QRS morphology for a bundle branch block, either of which can fully explain a discordant elevation confined to V1-V3 without further workup.
• If the tracing shows the classic concave, stable, precordial or inferolateral pattern of benign early repolarization in a young, asymptomatic patient, ongoing monitoring rather than acute escalation is appropriate — but avoid making that call in a patient over 50 or with risk factors for ischemic heart disease without first excluding the higher-acuity causes above.